The US Food and Drug Administration has officially approved AbbVie's EMBLAVEO™ (aztreonam and avibactam) as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination...
Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a pioneering developer of connected...
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, has officially announced new...
Egnyte, a leader in secure content collaboration and governance, has officially signed off on a partnership with Espero, a pioneer in clinical trial eProtocol...
C2N Diagnostics has officially published results from a study, which revealed that healthcare providers were able to enhance their ability in making Alzheimer’s disease...
